| Bioactivity | AZ513 is a reversible FAAH inhibitor with an IC50s of 551 nM and 27 nM for human FAAH and rat FAAH, respectively. AZ513 inhibits Anandamide (HY-10863) hydrolysis in human FAAH-transfected HEK293 cells (IC50 of 360 nM)[1]. |
| Target | IC50: 551 nM (human FAAH) and 27 nM (rat FAAH) |
| CAS | 1335231-15-6 |
| Formula | C14H9Cl2N3O |
| Molar Mass | 306.15 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Scott CW, et al. Biochemical characterization and in vitro activity of AZ513, a noncovalent, reversible, and noncompetitive inhibitor of fatty acid amide hydrolase. Eur J Pharmacol. 2011 Sep 30;667(1-3):74-9. |